Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole for angiogenic markers in preeclampsia
NL-OMON22488Recruiting
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of omeprazole in preeclampsia (2 arms), sponsored by None. Primary endpoint: Difference in sFlt-1 levels. Started Dec 2018; status: recruiting.
02
Drugs
omeprazole
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NL-OMON22488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22488.